PACS Group (PACS) awards 30,000 restricted stock units to Chief Compliance Officer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received an award of 30,000 shares of common stock in the form of restricted stock units. Each RSU converts into one share upon vesting. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of December 1, 2025, contingent on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Priegnitz Kelly
Role
Chief Compliance Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 30,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 30,000 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did PACS (PACS) disclose for Kelly Priegnitz?
PACS disclosed that Chief Compliance Officer Kelly Priegnitz was granted 30,000 restricted stock units tied to common stock. These RSUs represent a compensation award rather than an open-market purchase, aligning her interests with long-term company performance.
What is the vesting schedule for Kelly Priegnitz’s PACS (PACS) RSU grant?
The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of December 1, 2025. Vesting is conditioned on Kelly Priegnitz’s continued service with PACS Group through each applicable vesting date.
Did Kelly Priegnitz pay cash for the PACS (PACS) RSU award?
The transaction price per share is reported as $0.0000, indicating the 30,000 restricted stock units were granted as equity compensation. This reflects an award from the company, not an open-market purchase funded with personal cash.
What type of transaction code appears in the PACS (PACS) Form 4 for this grant?
The transaction is coded “A,” which the filing describes as a grant, award, or other acquisition. This confirms the 30,000-unit position reflects a compensatory equity award to the PACS Chief Compliance Officer rather than a market trade.